Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial. Han DH, Duan F, Wu Y, Goo JM, et al. J Thorac Oncol 2021;16:1118-1126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han DH, Duan F, Wu Y, Goo JM, et al. Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial. J Thorac Oncol 2021;16:1118-1126.
PMID: 33722708